当前位置:首页 >财报库 > 报告详情

麦克森Mckesson(MCK) 2025财年10-K年度报告「NYSE」(英文版)(461页).pdf

上传人: Kell****reet 编号:652279 2025-05-13 461页 3.60MB

下载:

1、Table of Contents UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-KANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended March 31,2025ORTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF

2、 1934For the transition period from to Commission File Number:1-13252McKESSON CORPORATION(Exact name of registrant as specified in its charter)Delaware 94-3207296(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)6555 State Hwy 161,Irving,TX 75039(Addres

3、s of principal executive offices,including zip code)(972)446-4800(Registrants telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:(Title of each class)(Trading Symbol)(Name of each exchange on which registered)Common stock,$0.01 par valueMCKNew York Stock E

4、xchange1.500%Notes due 2025MCK25New York Stock Exchange1.625%Notes due 2026MCK26New York Stock Exchange3.125%Notes due 2029MCK29New York Stock ExchangeSecurities registered pursuant to Section 12(g)of the Act:NoneIndicate by check mark if the registrant is a well-known seasoned issuer,as defined in

5、Rule 405 of the Securities Act.Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d)of the Act.Yes No Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange

6、Act of 1934 during thepreceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject to such filing requirements for the past 90days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文主要介绍了McKesson Corporation的业务概况。McKesson Corporation是一家多元化的医疗保健服务领导者,致力于在全球范围内提高患者的健康成果。公司通过四个报告部门运营:美国药品、处方技术解决方案、医疗外科解决方案和国际部门。美国药品部门在美国分销品牌药品、通用药品、特种药品、生物仿制药和非处方药品,并提供实践管理、技术、临床支持和商业解决方案。处方技术解决方案部门通过连接患者、药房、提供者、药房福利管理、健康计划和生物制药公司,解决患者用药获取、负担能力和依从性挑战。医疗外科解决方案部门为医疗保健提供者提供医疗外科供应分销、物流和其他服务。国际部门在加拿大和挪威为批发、机构和零售客户提供分销和服务。此外,文章还提到了公司的竞争情况、专利、商标、版权和许可、人力资本、政府监管、环境法规、反垄断法等关键信息。
McKesson公司面临哪些主要竞争? McKesson公司如何保护其知识产权? McKesson公司如何应对日益严格的政府监管?
客服
商务合作
小程序
服务号
折叠